Semler Scientific, Inc. (SMLR)

Market Cap	163.79M
Revenue (ttm)	65.88M
Net Income (ttm)	21.69M
Shares Out	7.07M
EPS (ttm)	2.78
PE Ratio	8.28
Forward PE	14.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,393
Open	23.71
Previous Close	23.67
Day's Range	23.01 - 23.93
52-Week Range	20.88 - 53.38
Beta	0.92
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2024

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 92
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR

Financial Performance

In 2023, SMLR's revenue was $68.18 million, an increase of 20.28% compared to the previous year's $56.69 million. Earnings were $20.58 million, an increase of 43.69%.